- Home
- ZKIN vs NERV Comparison
ZKIN vs NERV Comparison
Compare ZKIN & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKIN
- NERV
- Stock Information
- Founded
- ZKIN 2015
- NERV 2007
- Country
- ZKIN China
- NERV United States
- Employees
- ZKIN N/A
- NERV N/A
- Industry
- ZKIN Metal Fabrications
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- ZKIN Industrials
- NERV Health Care
- Exchange
- ZKIN Nasdaq
- NERV Nasdaq
- Market Cap
- ZKIN 12.6M
- NERV 12.6M
- IPO Year
- ZKIN 2017
- NERV 2014
- Fundamental
- Price
- ZKIN $1.95
- NERV $1.77
- Analyst Decision
- ZKIN
- NERV Hold
- Analyst Count
- ZKIN 0
- NERV 1
- Target Price
- ZKIN N/A
- NERV $5.00
- AVG Volume (30 Days)
- ZKIN 34.4K
- NERV 12.2K
- Earning Date
- ZKIN 01-27-2025
- NERV 08-05-2025
- Dividend Yield
- ZKIN N/A
- NERV N/A
- EPS Growth
- ZKIN N/A
- NERV N/A
- EPS
- ZKIN N/A
- NERV 0.83
- Revenue
- ZKIN $108,199,877.00
- NERV N/A
- Revenue This Year
- ZKIN N/A
- NERV N/A
- Revenue Next Year
- ZKIN N/A
- NERV N/A
- P/E Ratio
- ZKIN N/A
- NERV $2.18
- Revenue Growth
- ZKIN N/A
- NERV N/A
- 52 Week Low
- ZKIN $0.82
- NERV $1.15
- 52 Week High
- ZKIN $6.30
- NERV $3.50
- Technical
- Relative Strength Index (RSI)
- ZKIN 41.68
- NERV 57.10
- Support Level
- ZKIN $1.85
- NERV $1.62
- Resistance Level
- ZKIN $2.12
- NERV $1.83
- Average True Range (ATR)
- ZKIN 0.18
- NERV 0.09
- MACD
- ZKIN -0.07
- NERV -0.00
- Stochastic Oscillator
- ZKIN 11.67
- NERV 64.29
About ZKIN ZK International Group Co. Ltd
ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.